Skip to main content

Day: November 28, 2022

HEMPSANA Announces Q3 2022 Financial Results

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES. TORONTO, Nov. 28, 2022 (GLOBE NEWSWIRE) — Hempsana Holdings Ltd. (the “Company” or “Hempsana”) today announced three and nine months financial results for the period ended September 30, 2022. Randy Ko, Hempsana’s CEO commented: “Our team remains focused on leading the market in the manufacturing and distribution of rare cannabinoids to support product development cycles with many of the major consumer brand leaders in Canada. Our management team continues to keep their ears to the ground on consumer data driven insights, innovation and brand development as we continue to expand on our strategic partnership program to bring unique products to market....

Continue reading

Viridian Therapeutics To Participate In The Evercore ISI HealthCONx Conference

WALTHAM, Mass., Nov. 28, 2022 (GLOBE NEWSWIRE) — Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company advancing new treatments for patients suffering from serious diseases underserved by current therapies, today announced that senior management will participate in the 5th Annual Evercore ISI HealthCONx Conference on Thursday, December 1, 2022.   Evercore ISI HealthCONx ConferenceFormat:         Fireside Chat  Date:             December 1, 2022    Time:  10:30 a.m. ETThe live webcast of the fireside chat will be accessible under “Events and Presentations” within “News and Events” on the Investors section of the Viridian website at viridiantherapeutics.com. A replay of the webcast will be available on the Company’s website after the event. About Viridian Therapeutics Viridian Therapeutics is a...

Continue reading

Vigil Neuroscience to Host ALSP KOL Event on December 6, 2022

CAMBRIDGE, Mass., Nov. 28, 2022 (GLOBE NEWSWIRE) — Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative diseases, today announced that the Company will host an adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP) Key Opinion Leader (KOL) event for the investment community in New York City on Tuesday, December 6, 2022, from 8:30 a.m. – 11:30 a.m. ET. The event will provide further details on the ALSP disease background, epidemiology and patient journey. In addition, the Company plans to present the VGL101 Phase 2 trial design and objectives as well as interim MRI data from Illuminate, the ongoing natural history study. The Vigil management team will be joined by:David S. Lynch, MD, PhD, Consultant...

Continue reading

Treasure Global Launches ZCITY App Campaign With Leading Retail Petroleum Company In Malaysia

Campaign Allows App Users To Spend And Become Eligible To Win Six Months Free Petrol In Malaysia NEW YORK and KUALA LUMPUR, Malaysia, Nov. 28, 2022 (GLOBE NEWSWIRE) — Treasure Global Inc (NASDAQ: TGL) (“TGI” or the “Company”), an innovative e-commerce platform providing seamless payment solutions and rewards programs, today announced that it has launched a campaign with the leading retail petroleum company in Malaysia, through its proprietary application, ZCITY, to provide users with the chance to win six months of complimentary fuel when they spend through the ZCITY App. The campaign, which will run through December 31, 2022, allows users who spend a minimum of RM30 on ZCITY e-Vouchers for this retailer’s petrol to go in the drawing to be one of the 60 winners to win free fuel for six months. The Company will select 20 winners...

Continue reading

PDD Announces Third Quarter 2022 Unaudited Financial Results

SHANGHAI, Nov. 28, 2022 (GLOBE NEWSWIRE) — PDD (the “Company”) (NASDAQ: PDD), today announced its unaudited financial results for the third quarter ended September 30, 2022. Third Quarter 2022 HighlightsTotal revenues in the quarter were RMB35,504.3 million (US$1 4,991.1 million), an increase of 65% from RMB21,505.8 million in the same quarter of 2021.Operating profit in the quarter was RMB10,436.6 million (US$1,467.2 million), an increase of 388% from RMB2,139.3 million in the same quarter of 2021. Non-GAAP2 operating profit in the quarter was RMB12,301.5 million (US$1,729.3 million), an increase of 277% from RMB3,260.7 million in the same quarter of 2021.Net income attributable to ordinary shareholders in the quarter was RMB10,588.6 million (US$1,488.5 million), an increase of 546% from RMB1,640.0 million in the same quarter...

Continue reading

H World Group Limited Reports Third Quarter of 2022 Unaudited Financial Results

A total of 8,402 hotels or 797,489 hotel rooms in operation as of September 30, 2022. Hotel turnover1 increased 24.4% year-over-year to RMB15.2 billion in the third quarter of 2022. Excluding Steigenberger Hotels AG and its subsidiaries (“DH”, or “Legacy-DH”), hotel turnover increased 21.6% year-over-year in the third quarter of 2022. Revenue increased 16.2% year-over-year to RMB4.1 billion (US$575 million)2 in the third quarter of 2022, in line with the revenue guidance previously announced of a 13% to 17% increase compared to the third quarter of 2021. Revenue from the Legacy-Huazhu segment in the third quarter of 2022 increased 7.7% year-over-year, in line with revenue guidance previously announced of a 5% to 9% increase. Net loss attributable to H World Group Limited was RMB717 million (US$101 million) in the third quarter of 2022,...

Continue reading

Fusion Fuel Green Hosts Third Quarter 2022 Investor Update

SABUGO, Portugal, Nov. 28, 2022 (GLOBE NEWSWIRE) — Fusion Fuel Green PLC (NASDAQ: HTOO) (“Fusion Fuel”), an emerging leader in the green hydrogen sector, today announced financial results for the third quarter ended September 30, 2022. The quarterly shareholder letter is available at https://ir.fusion-fuel.eu/financials-filings/earnings-releases Third Quarter 2022 HighlightsReceived approval for €10 million in grant funding from C-14 of PRR to develop the HEVO-Industria project in Sines​​ Announced completion independent technology assessment of Fusion Fuel and HEVO-Solar system​ by Black & Veatch Announced completion of three-month performance audit ​of HEVO-Solar system​ by TUV SUD Commenced construction on Exolum project in Madrid, Spain​ Filed two additional patents​Subsequent Events​Announced €5 million...

Continue reading

Kraken Receives $14 Million Order for Subsea Power Systems

ST. JOHN’S, Newfoundland and Labrador, Nov. 28, 2022 (GLOBE NEWSWIRE) — Kraken Robotics Inc. (TSX-V: PNG, OTCQB: KRKNF) announces that it has received an initial order for subsea batteries valued at $14 million, which includes a significant advance payment. Deliveries will occur in 2023. Kraken’s SeaPower® 6000-meter rated pressure tolerant batteries are based on Kraken’s unique pressure tolerant gel encapsulation technology for lithium polymer batteries. This provides an attractively priced, environmentally friendly, and superior energy density alternative to the traditional oil compensated batteries commonly used for deep subsea battery applications. Kraken’s hot swappable batteries are modular and include an integrated battery management system within each battery module which provides a very high level of redundancy and safety. LINKSwww.krakenrobotics.com SOCIAL...

Continue reading

RadNet’s Aidence Artificial Intelligence (AI) Subsidiary and Google Health Enter into Collaboration to Help Improve Lung Cancer Screening with AI Solutions

LOS ANGELES, Nov. 28, 2022 (GLOBE NEWSWIRE) — RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services today reported that its lung artificial intelligence subsidiary, Aidence, and Google Health, a division of Alphabet, Inc. (NASDAQ: GOOG), announce an agreement to license Google Health’s AI research model for lung nodule malignancy prediction on CT imaging. Aidence will develop, validate and bring this model to the market to support the early and accurate diagnosis of lung cancer and the reduction of unnecessary procedures in screening programs. Lung cancer screening with low-dose CT has been shown to significantly reduce lung cancer mortality by as high as 24% for men and 33% for women, according to the 2020 NELSON trial. Screening initiatives...

Continue reading

Ascendant Resources Closes US$15 Million Financing Agreement With Sprott Streaming for Its Lagoa Salgada Project, Portugal

Funding to complete Feasibility Study and lead to a construction decision in Q2 2023 TORONTO, Nov. 28, 2022 (GLOBE NEWSWIRE) — Ascendant Resources Inc. (TSX: ASND, OTCQB: ASDRF) (“Ascendant” or the “Company”) is very pleased to announce it has entered into a US$15 million metals stream agreement (the “Stream Agreement”) with Sprott Private Resource Streaming and Royalty Corp. (“Sprott Streaming”) for its Lagoa Salgada VMS project located close to Lisbon, Portugal (the “Project”). Proceeds will be used to i) complete the ongoing 43-101 compliant feasibility study for the Project; ii) advance permitting activities; iii) to fund the last instalment related to the earn-in for an 80% interest in the Project; and iii) general corporate and working capital purposes. The Stream Agreement provides for the sale and delivery to Sprott Streaming...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.